Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Essex Woodlands Management Inc., the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention EyePoint Pharmaceuticals, Inc., all published on February 28, 2026.
Last mentioned: Feb 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Essex Woodlands Management Inc., the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention EyePoint Pharmaceuticals, Inc., all published on February 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering EyePoint Pharmaceuticals, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Essex Woodlands Management Inc. reduced its position in EyePoint Pharmaceuticals by 7.3% during the third quarter, selling 85,000 shares. Despite the reduction, the firm maintains a high-conviction $15.45 million stake, representing 5% of its total investment portfolio.
EyePoint Pharmaceuticals, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
